ES351661A1 - Procedure for the manufacture of new 18-methyl-19-nor-17-alpha-hydroxyprogesterons and their 3-enol-17-di-0-17-monoesteres. (Machine-translation by Google Translate, not legally binding) - Google Patents
Procedure for the manufacture of new 18-methyl-19-nor-17-alpha-hydroxyprogesterons and their 3-enol-17-di-0-17-monoesteres. (Machine-translation by Google Translate, not legally binding)Info
- Publication number
- ES351661A1 ES351661A1 ES351661A ES351661A ES351661A1 ES 351661 A1 ES351661 A1 ES 351661A1 ES 351661 A ES351661 A ES 351661A ES 351661 A ES351661 A ES 351661A ES 351661 A1 ES351661 A1 ES 351661A1
- Authority
- ES
- Spain
- Prior art keywords
- methyl
- alpha
- enol
- diol
- ether
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 abstract 2
- 229960002899 hydroxyprogesterone Drugs 0.000 abstract 2
- CRMOMCHYBNOFIV-BDXSIMOUSA-N 16-estratetraen-3-ol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C=CC4)[C@@H]4[C@@H]3CCC2=C1 CRMOMCHYBNOFIV-BDXSIMOUSA-N 0.000 abstract 1
- -1 20,20 - Ethylenedioxy Chemical group 0.000 abstract 1
- 235000018185 Betula X alpestris Nutrition 0.000 abstract 1
- 235000018212 Betula X uliginosa Nutrition 0.000 abstract 1
- 230000000887 hydrating effect Effects 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 150000002730 mercury Chemical class 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- 238000010561 standard procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Abstract
The novel 18 - methyl - 19 - nor - 17[alpha] - hydroxy - progesterone, the corresponding 4,6 - diene and their 3 - enol - 17[alpha] - diesters and 17[alpha]- monoesters are prepared by reducing by the Birch method or electrolytically an 18 - methyl- 19 - nor - #1,3,5(10) - pregnatriene - 3,17[alpha]- diol - 20 - one 3 - alkyl ether 20 - ketal and hydrolysing the product (the corresponding #2,5(10) - diene) to give 18 - methyl - 19 - nor- 17[alpha] - hydroxy - progesterone and, if desired, converting this to the other products by standard procedures. 20,20 - Ethylenedioxy - 18 - methyl - 19 - nor- #1,3,5(10) - pregnatriene - 3,17[alpha] - diol 3 - methyl ether is prepared by oxidizing 3 - methoxy - 18- methyl - #1'3'5(10) - estratrien - 17# - ol to the 17- one, converting this to 17[alpha] - ethynyl - 18 - methyl- #1'3,5(10) - estratrien - 3,17# - diol 3 - methyl ether, dehydrating this to 17 - ethynyl - 18 - methyl- #1'3'5(10)'16 - estratetraen - 3 - ol 3 - methyl ether, hydrating this in the presence of a mercury salt to give 18 - methyl - 19 - nor - #1,3,5(10),16 - pregnatetraen - 3 - ol - 20 - one 3 - methyl ether, epoxidizing this to give 16[alpha],17[alpha] - oxido - 18 - methyl- 19 - nor - #1'3'5(10) - pregnatrien - 3 - ol - 20 - one 3 - methyl ether, converting this via the 16, 17- bromohydrin into 18 - methyl - 19 - nor - #1,3,5(10)- pregnatriene - 3,17[alpha] - diol - 20 - one 3 - methyl ether and ketalizing this.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DESC040657 | 1967-05-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES351661A1 true ES351661A1 (en) | 1969-06-01 |
Family
ID=7435799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES351661A Expired ES351661A1 (en) | 1967-05-05 | 1968-03-15 | Procedure for the manufacture of new 18-methyl-19-nor-17-alpha-hydroxyprogesterons and their 3-enol-17-di-0-17-monoesteres. (Machine-translation by Google Translate, not legally binding) |
Country Status (13)
Country | Link |
---|---|
AT (1) | AT279819B (en) |
BE (1) | BE714593A (en) |
CA (1) | CA923891A (en) |
CH (2) | CH581150A5 (en) |
CS (1) | CS150217B2 (en) |
DK (1) | DK119976B (en) |
ES (1) | ES351661A1 (en) |
FI (1) | FI45175C (en) |
FR (2) | FR1581520A (en) |
GB (1) | GB1226356A (en) |
NL (1) | NL160276C (en) |
NO (1) | NO127194B (en) |
SE (1) | SE335856B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5655400A (en) * | 1979-10-12 | 1981-05-15 | Mitsubishi Chem Ind Ltd | Improved preparation process of 4,6-dien-3-one steroid |
HU216828B (en) * | 1995-12-22 | 1999-09-28 | Richter Gedeon Vegyészeti Gyár Rt. | Steroids, process for producing them, pharmaceutical compositions containing them and their intermediates |
HUP0301332A3 (en) * | 2003-05-14 | 2006-04-28 | Richter Gedeon Vegyeszet | New mono-and bismethylene steroid derivatives and process for their synthesis and pharmaceutical compositions containing them |
-
1968
- 1968-02-29 CH CH296668A patent/CH581150A5/xx not_active IP Right Cessation
- 1968-03-06 FI FI680607A patent/FI45175C/en active
- 1968-03-12 AT AT244868A patent/AT279819B/en not_active IP Right Cessation
- 1968-03-12 CS CS1920A patent/CS150217B2/cs unknown
- 1968-03-15 ES ES351661A patent/ES351661A1/en not_active Expired
- 1968-03-19 DK DK116668AA patent/DK119976B/en unknown
- 1968-03-26 SE SE04008/68A patent/SE335856B/xx unknown
- 1968-04-02 GB GB1226356D patent/GB1226356A/en not_active Expired
- 1968-05-03 BE BE714593D patent/BE714593A/xx not_active IP Right Cessation
- 1968-05-03 NL NL6806348.A patent/NL160276C/en not_active IP Right Cessation
- 1968-05-03 CA CA019125A patent/CA923891A/en not_active Expired
- 1968-05-03 FR FR1581520D patent/FR1581520A/fr not_active Expired
- 1968-05-03 NO NO01721/68A patent/NO127194B/no unknown
- 1968-08-01 FR FR161486A patent/FR8084M/fr not_active Expired
-
1974
- 1974-10-07 CH CH296668A patent/CH563408A5/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NL6806348A (en) | 1968-11-06 |
CA923891A (en) | 1973-04-03 |
NO127194B (en) | 1973-05-21 |
FI45175C (en) | 1972-04-10 |
SE335856B (en) | 1971-06-14 |
GB1226356A (en) | 1971-03-24 |
DK119976B (en) | 1971-03-22 |
NL160276B (en) | 1979-05-15 |
FR1581520A (en) | 1969-09-19 |
BE714593A (en) | 1968-11-04 |
AT279819B (en) | 1970-03-25 |
DE1643020A1 (en) | 1971-04-15 |
FI45175B (en) | 1971-12-31 |
CH563408A5 (en) | 1975-06-30 |
NL160276C (en) | 1979-10-15 |
CH581150A5 (en) | 1976-10-29 |
FR8084M (en) | 1970-07-20 |
CS150217B2 (en) | 1973-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA957942A (en) | Flowable pancreatin preparation of low germ content, and a process for its manufacture | |
ES351661A1 (en) | Procedure for the manufacture of new 18-methyl-19-nor-17-alpha-hydroxyprogesterons and their 3-enol-17-di-0-17-monoesteres. (Machine-translation by Google Translate, not legally binding) | |
GB945518A (en) | Improvements in or relating to steroid syntheses | |
ES446637A1 (en) | Acellular vaccines | |
CA933516A (en) | Cyclic ethers of cardenolide digitoxosides, process therefor and compositions thereof | |
ES322427A1 (en) | Procedure for the obtaining of a composition used as excipient in pharmaceutical preparations. (Machine-translation by Google Translate, not legally binding) | |
ES309246A1 (en) | Procedure for the preparation of estradiol ester. (Machine-translation by Google Translate, not legally binding) | |
GB1298316A (en) | A method for reducing zearalenone to zearalanol | |
GB1128789A (en) | 7ª-alkyl-5(10),9(11)-diene steroids | |
ES376875A1 (en) | Process for the preparation of 5-bromo-6-fluoro-steroids | |
ES277176A1 (en) | Procedure for preparation of 18,19-dinor 13 beta N-propil 17 alpha-etinil testosterone (Machine-translation by Google Translate, not legally binding) | |
ES397035A1 (en) | Antiinflammatory preparations | |
ES297197A1 (en) | A procedure for the preparation of 8-iso 17-alpha-etinil estradiol (Machine-translation by Google Translate, not legally binding) | |
ES272931A1 (en) | A PROCEDURE FOR THE PREPARATION OF 17-ALPHA-ETHINYL 18-NOR 13-BETA-N-PROPIL ESTRADIOL AND ITS ESTERS AND ETHERS (Machine-translation by Google Translate, not legally binding) | |
GB1171128A (en) | Process for the Preparation of 4alpha-Hydroxy-5beta-Steroids | |
ES321325A2 (en) | A procedure for preparation of steroid derivatives. (Machine-translation by Google Translate, not legally binding) | |
ES383319A1 (en) | Process for preparing useful 17alpha-hydroxy-20-keto-and 17alpha, 21-dihydroxy-20-keto-pregnanes and derivatives and intermediates thereof | |
ES276364A1 (en) | Procedure for the preparation of 3-oxo-17-beta-hydroxy 5- (10) -train (Machine-translation by Google Translate, not legally binding) | |
GB1087753A (en) | 5ª-androstane-1ª,17ª-diol-3-one and a process for its manufacture | |
ES202087A1 (en) | Industrial procedure for the obtaining of a perfumery product (Machine-translation by Google Translate, not legally binding) | |
ES229817A1 (en) | Procedure for the preparation of 16 alpha, 17alfa-oxido-5alfa- and 5 beta-pregnano-3, 11, 20-triona (Machine-translation by Google Translate, not legally binding) | |
CA595248A (en) | METHOD OF PRODUCING .alpha.-BROMINATED KETO STEROID COMPOUNDS | |
GB1094390A (en) | Preparation of í¸-pregnatriene compounds | |
ES327372A1 (en) | A procedure for the preparation of 3-oxo 13 beta-ethyl 17 alpha-etinyl 17 beta-hydroxy gone -4,9,11-triene. (Machine-translation by Google Translate, not legally binding) | |
AU218091B2 (en) | Improvements in or relating to glow discharge tubes having an activated cathode and improved methods of producing tubes containing such cathodes |